Teva Pharmaceutical Industries Limited (TEVA)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$31.69
+1.34%
Mkt Cap $36.69B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$38.33
Range $35.00 – $41.00
Implied Upside
+21.0%
Consensus $38.33 vs current $31.69